Cautious Venture Capital Commands Medtech Start-Ups To Think Long-Term
This article was originally published in The Gray Sheet
Executive Summary
A growing emphasis on evidence-based medicine is compelling medtech start-ups to seek consultation in developing a reimbursement strategy